Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer.

Cell Death Dis · 2020 · PMC7678839 · PMID 33214550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

6a ), which showed a trend similar to TNFα changes in different TNM stage of clinical samples’ microarray ( GSE103668 ) (Fig. 6b ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.